Abnormal Stat Activation, Hematopoietic Homeostasis, and Innate Immunity in c-fes−/− Mice  by Hackenmiller, Renee et al.
Immunity, Vol. 13, 397–407, September, 2000, Copyright ª 2000 by Cell Press
Abnormal Stat Activation, Hematopoietic
Homeostasis, and Innate Immunity in c-fes2/2 Mice
kinase Fes phosphorylates and activates Stat3 in re-
sponse to GM-CSF stimulation (Nelson et al., 1998; Park
et al., 1998). Furthermore, GM-CSF stimulation of neu-
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Jak-Stat pathway in the context of GM-CSF signaling.University of Maryland School of Medicine
Fes is a 93 kDa nonreceptor protein tyrosine kinaseBaltimore, Maryland 21201
encoded by the c-fes protooncogene expressed pre-
dominantly in myeloid cells (Feldman et al., 1985; Mac-
Donald et al., 1985; Smithgall et al., 1988) and vascular
Summary endothelial cells (Greer et al., 1994). The Fes protein
includes amino-terminal coiled-coil motifs, a central SH2
The c-fes protooncogene encodes a nonreceptor tyro- domain, and the carboxyl-terminal catalytic domain. Fes
sine kinase (Fes) implicated in cytokine receptor signal expression is highest in mature granulocytes and mono-
transduction, neutrophil survival, and myeloid differ- cytes, and terminal differentiation of myeloid cells is
associated with increased levels of c-fes mRNA (Lieber-entiation. To determine the role of Fes in embryonic
mann and Hoffman-Liebermann, 1989) as well as in-development and hematopoiesis, we engineered a null
creased Fes catalytic activity (Glazer et al., 1986; Smith-mutation of the murine c-fes locus. c-fes2/2 mice are
gall et al., 1988; Yu et al., 1988). This pattern ofviable but not born in the expected Mendelian ratios.
expression in myeloid cells suggests that Fes plays aLive born c-fes2/2 mice exhibit lymphoid/myeloid ho-
role in normal myeloid development and/or function.meostasis defects, compromised innate immunity,
Additional experiments implicate Fes as an importantand increased Stat activation in response to GM-CSF
regulatory gene in myeloid cell survival and terminaland IL-6 signaling. Therefore, increased cytokine re-
differentiation; in particular, the introduction of c-fes intosponsiveness in the absence of Fes leads to abnormal
immature K562 leukemia cells restores their ability tomyeloid proliferation and functional defects in the
undergo myeloid differentiation (Yu et al., 1989). More-
macrophage lineage. over, inhibition of c-fes expression in HL60 cells by anti-
sense oligonucleotides leads to a complete block in
Introduction granulocyte differentiation due to the activation of pro-
grammed cell death (Ferrari et al., 1992; Manfredini et
Growth, differentiation, and normal function of the im- al., 1993).
mune system are regulated by multiple hematopoietic The association of Fes with hematopoietic cytokine
cytokines, including the interleukins and colony-stimu- receptors provides compelling evidence that Fes is a
lating factors (Arai et al., 1990). Cytokine stimulation component of myeloid signaling pathways. Fes is phos-
involves ligand binding to specific cell-surface recep- phorylated and catalytically activated in response to
tors, activation of intracellular signaling molecules, and stimulation by a number of cytokines, including IL-3,
changes in nuclear gene expression. Jak-Stats repre- GM-CSF, erythropoietin, and IL-4 (Hanazono et al., 1993,
sent one of the best characterized signal transduction 1993; Izuhara et al., 1994; Linnekin et al., 1995), and
pathways that function downstream of hematopoietic association of Fes with the common b chain of the IL-3
cytokine receptors and are activated by cytokines such and GM-CSF receptors has been reported (Hanazono
as granulocyte colony-stimulating factor (G-CSF), eryth- et al., 1993). Fes has also been shown to form a complex
ropoietin, thrombopoietin, the interferons, and numer- with gp130, the common signal-transducing component
ous interleukins (Darnell et al., 1994; Ihle et al., 1995; of the receptors for IL-6, leukemia inhibitory factor, on-
Darnell, 1997). Ligand/cytokine receptor interactions ac- costatin M, and IL-11 (Matsuda et al., 1995). These ob-
tivate the Janus kinase (Jak) family of protein tyrosine servations strongly suggest involvement of Fes in signal-
kinases, which in turn phosphorylate latent cytoplasmic ing pathways emanating from several different cytokine
Stat (signal transducer and activator of transcription) receptors.
proteins. Active, phosphorylated Stats dimerize and Many possible substrates for Fes have been identi-
translocate to the nucleus, where they regulate the tran- fied, but its proposed associations with the BCR (break
scription of genes mediating cytokine-induced biologi- point cluster region) protein, Syk, Stat1, and Stat3 are
cal responses. particularly intriguing, given that these proteins play im-
Recently, it has been shown that Jak-Stat pathways portant roles in myeloid development. Fes has been
are not simple, two-component signaling systems; posi- shown to associate with BCR through its N-terminal
tive and negative regulators modulate Jaks and Stats domain, and this interaction alters Ras signaling path-
at every step, from surface cytokine receptor to target ways (Li and Smithgall, 1996). Fes may also play a role
gene transcription. Other kinases, in addition to Jaks, in Syk-mediated FCgR signaling, as the SH2 domain of
can activate Stat proteins; for example, the tyrosine Syk includes an ideal predicted binding site for auto-
phosphorylated Fes tyrosine 811 (Songyang et al., 1994).
Finally, the ability of Fes to bind and activate Stat3 in§ To whom correspondence should be addressed (e-mail: celeste2@
mail.med.upenn.edu). response to GM-CSF signaling implicates Fes in the
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Figure 1. Targeted Disruption of the c-fes
Locus
(A) The murine c-fes locus with exons (boxes)
and relevant restriction sites is shown at the
top. The middle diagram shows the targeting
construct, designed to delete the promoter
and translational start codon and replace
them with PGK-neo. To enrich for homolo-
gous recombination events, HSV-TK was em-
ployed for negative selection against random
integration events. The bottom diagram rep-
resents the correctly disrupted c-fes locus.
The position of the probe used for RFLP anal-
ysis is indicated. B, BglII; S, Sphl; XN, Xmnl;
X, Xbal; XH, Xhol; and N, Notl.
(B) Southern blot analysis of genomic DNA
from targeted ES cells. Wild-type (9.4 kb) and
disrupted (7.0 kb) BglII fragments are indi-
cated. Lane 2 shows DNA from ES cells de-
rived from the primary targeting event; lane
3 shows DNA from ES cells grown in 1.5 mg/
ml G418 to select for c-fes2/2 cells. Geno-
types are indicated.
(C) In vitro differentiated c-fes2/2 ES cells pro-
duce no Fes protein. Western blot of anti-Fes
immunoprecipitates of in vitro differentiated
monocyte cell extracts from c-fes1/1 (1/1),
c-fes1/2 (1/2), and c-fes2/2 (2/2) cultures
were probed with a Fes monoclonal antibody.
J774.1 is a mouse macrophage cell line used
as a positive control for Fes protein detection.
The 2/2 lane demonstrates the complete ab-
sence of Fes protein in the c-fes2/2 ES cells.
The 1/2 lane demonstrates that c-fes1/2
cells express approximately half as much Fes
as the wild-type (1/1) cells. Approximate size
standards are indicated on the right.
Jak-Stat pathway (Brizzi et al., 1996; Nelson et al., 1998; addition to the wild-type 9.4 kb fragment. Heterozygous
(c-fes1/2) ES cells were obtained (Figure 1B, lane 2) andPark et al., 1998).
Despite substantial data implicating Fes in myeloid used to generate c-fes2/2 ES cells by selection in high
G418 concentrations (Mortensen et al., 1992) (Figurecell signaling and differentiation, the function of Fes in
myeloid development has not been clearly defined. To 1B, lane 3). Absence of Fes protein was confirmed by
immunoprecipitation and Western blot analysis of instudy the function of Fes in myeloid cell signaling and
function, we generated a targeted disruption of the c-fes vitro differentiated c-fes2/2 ES cells (Figure 1C). Wild-
type (1/1) cultures expressed high levels of the Feslocus. This targeted allele results in a null mutation,
expressing no detectable Fes protein. c-fes2/2 mice ex- protein, while c-fes1/2 (1/2) cultures expressed approx-
imately half of wild-type levels, and c-fes2/2 (2/2) cul-hibit homeostasis defects in B cells, macrophages, and
neutrophils, compromised innate immunity, and in- tures expressed no detectable Fes protein. Western
blots were performed with polyclonal and two separate,creased activation of Stat3 and Stat5 in response to
IL-6 and GM-CSF. These results demonstrate that Fes Fes-specific monoclonal antibodies with identical re-
sults obtained in each analysis. We concluded that thisregulates Stat activation during cytokine-mediated sig-
nal transduction. mutation produced a null allele of c-fes, expressing no
detectable Fes protein.
Undifferentiated c-fes1/2 ES cells were injected intoResults
C57BL/6 blastocysts to generate c-fes1/2 animals.
c-fes1/2 X c-fes1/2 matings established that c-fes2/2Disruption of the c-fes Gene and Generation
mice are viable but not born in the expected Mendelianof c-fes2/2 Mice
ratios. Intercrosses of heterozygous mice producedTo investigate the function of Fes in vivo, we generated
30% c-fes1/1 (97 of 324), 51% c-fes1/2 (167 of 324), anda null mutation of the murine c-fes locus. Following ho-
18% c-fes2/2 (60 of 324) offspring, differing significantlymologous recombination, the targeting vector deleted
from the predicted Mendelian distribution (81 c-fes2/2the promoter and translational start codon of c-fes and
mice; P , 0.01 by x2 analysis). This appears to be due toreplaced it with the PGK-neo cassette (Figure 1A). Tar-
embryonic lethality and is currently being investigated. Itgeted embryonic stem (ES) cells were identified by pro-
duction of a novel 7.0 kb BglII restriction fragment in is likely that a percentage of the c-fes2/2 mice are dying
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Figure 2. c-fes Is Not Essential for the Production of Macrophages and Red Blood Cells
(A–C) May-Grunwald-Giemsa staining of in vitro differentiated c-fes1/1, c-fes1/2, and c-fes2/2 ES cells.
(D–F) CD11b antibody staining.
(G–I) F4/80 antibody staining for the same in vitro differentiated ES cells, shown in the order indicated for May-Grunwald-Giemsa staining.
in utero, since no postnatal lethality prior to the age of cytometry. Therefore, based on May-Grunwald-Giemsa
weaning was observed (data not shown). analysis, CD11b and F4/80 immunostaining, and flow
cytometry, Fes is not essential for the production of
erythrocytes, lymphocytes, granulocytes, or monocytes
c-fes2/2 Mice Exhibit Lymphoid and Myeloid in ES cell-derived EBs or mice.
Homeostasis Defects
Although all hematopoietic lineages were producedSince Fes is highly expressed in myeloid cells and re-
in the absence of Fes, c-fes2/2 mice displayed homeo-ported to regulate myeloid differentiation, we predicted
stasis defects, consistently showing decreased num-that its elimination would result in a severe decrease
bers of B lymphocytes (Figure 3B) and increased num-in myeloid cell numbers. Surprisingly, c-fes2/2 ES cells
bers of monocytes (Figure 3C) and neutrophils (Figuredifferentiated into both macrophages and neutrophils,
3D) by FACs (n 5 14 for each genotype). c-fes2/2as well as erythrocytes, monocytes, megakaryocytes,
CD11b1/CD181 monocyte numbers were elevated 2-foldand granulocytes upon in vitro culture as embryoid bod-
in the spleen and the bone marrow and 6- to 7-fold inies (EBs) (Keller et al., 1993). May-Grunwald-Giemsa-
the peripheral blood (Figure 3C). Furthermore, c-fes2/2stained cytospin preparations from c-fes1/1, c-fes1/2,
animals exhibited increased numbers of Gr-11 granu-and c-fes2/2 EBs after 11 days of in vitro differentiation
locytes (Figure 3D) in the bone marrow (15%–20% in-readily detected such cells in all three cultures (Figures
crease), in the spleen (4-fold increase), and in the periph-2A–2C). To confirm that macrophages were produced
eral blood (3- to 4-fold increase). In contrast to thein c-fes2/2 EBs, dissociated EBs were allowed to adhere
elevation in myeloid cell numbers, c-fes2/2 mice pro-to chamber slides and stained with antibodies to the
duced reduced numbers of B2201IgM1 cells (Figure 3B)macrophage-specific markers CD11b and F4/80. As
in the spleen (54% reduction) and peripheral blood (63%shown in Figure 2, adherent, CD11b1 (D–F), and F4/801
reduction). There were also fewer B2201IgM2 cells de-(G–I) macrophages (intense red stain) were present in
tected in the bone marrow (30% reduction) and periph-all three genotypes. In vivo, mature T (Figure 3A) and B
eral blood (75% reduction). c-fes1/2 animals occasion-lymphocytes (Figure 3B), monocytes (Figure 3C), and
ally demonstrated intermediate decreases in the samegranulocytes (Figure 3D) were detected in c-fes2/2 thy-
mus, bone marrow, spleen, and peripheral blood by flow cell lineages. Of note, all T cell populations examined
Immunity
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Figure 3. Decreased Number of B Lymphocytes and Increased Numbers of Myeloid Cells in c-fes2/2 Mice
(A) c-fes2/2 mice exhibit normal numbers of CD41 and CD81 T cells in the thymus, spleen, and lymph node. Assays were performed on
6-week-old littermates. Numbers indicate the percent of positive cells in each quadrant. 10,000 events were counted for each sample, and
representative FACS profiles are shown.
(B) c-fes2/2 mice exhibit fewer immature and mature B lymphocytes in the bone marrow, spleen, and peripheral blood as compared to wild-
type littermates. Flow cytometry performed on the indicated tissue specimens assayed for B220/IgM staining.
(C) c-fes2/2 mice exhibit increased numbers of monocytes in the bone marrow, spleen, and peripheral blood as compared to wild-type
littermates. Flow cytometry performed on the indicated tissue specimens assayed by CD18/CD11b staining is shown.
(D) c-fes2/2 mice exhibit increased numbers of GR-11 granulocytes in the bone marrow, spleen, and peripheral blood as compared to wild-
type littermates. Flow cytometry performed on the indicated tissue specimens assayed by Gr-1 staining is shown.
in the thymus, spleen, and peripheral blood were normal 4B). Pathology reports, FACs analysis, and physical ex-
amination of these runted c-fes2/2 mice established thatin both c-fes1/2 and c-fes2/2 animals (Figure 3A).
Bone marrow clonogenic assays revealed that the they were developmentally delayed as compared to
wild-type littermates and displayed a striking hypocellu-abnormal myeloid numbers in c-fes2/2 mice were not the
result of changes in hematopoietic progenitor numbers larity of the bone marrow and thymus. Older (6–10
weeks) c-fes2/2 mice frequently developed skin lesions(data not shown). c-fes1/2 and c-fes2/2 animals pro-
duced wild-type numbers of all bone marrow progenitor (Figures 4C and 4D) and conjunctivitis (see figure legend
for details). Some of the mice eventually cleared thetypes assayed (CFU-GEMM, CFU-G, CFU-M, CFU-GM,
and CFU-E). In contrast, spleen clonogenic assays dem- infection, but others succumbed to topical pathogen(s).
To determine whether c-fes2/2 animals have defects inonstrated that c-fes2/2 mice produced higher numbers
of CFU-M colonies (2-fold), indicating that extramedul- resistance to specific pathogens, wild-type and mutant
mice were infected with the protozoan Leishmania majorlary hematopoiesis occurred (data not shown). Taken
together, these results strongly suggest that Fes plays and the spirochete Borrelia burgdorferi, which causes
Lyme disease. Although both c-fes1/1 and c-fes2/2 micea critical role in myeloid and B cell homeostasis.
were resistant to L. major infection (data not shown),
c-fes2/2 mice displayed increased ankle swelling in re-Compromised Innate Immunity in the Absence
sponse to B. burgdorferi infection (data not shown).of c-fes
Importantly, no wild-type mice developed any notice-A number of 3-week-old c-fes2/2 mice appeared to be
runted, weak, and generally unhealthy (Figures 4A and able infections. Innate immunity appears to regulate the
Fes Regulates Stat Activation
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Figure 4. Runted and Unhealthy Appearance
of c-fes2/2 Mice
Photograph showing the runted, fragile ap-
pearance of a 3-week-old male c-fes2/2
mouse (B) compared to a female c-fes1/1 lit-
termate (A). This mouse is representative of
multiple c-fes2/2 mice that have presented
with similar phenotypes. (C) depicts a histo-
logic section of wild-type skin showing nor-
mal epidermis and dermis, while (D) shows
the ulcerated skin section from a c-fes2/2
mouse that exhibited large abdominal pus-
tules and many open wounds across its body.
The epidermis is replaced by a serocellular
crust containing large numbers of inflamma-
tory infiltrate and many dead neutrophils. In
c-fes2/2 sections, the normal structures of the
skin such as the dermis and subcutaneous
tissue are no longer recognizable. Magnifica-
tion in (C) and (D) 5 403.
severity of disease induced by B. burgdorferi, as mice process. Such adhesion events result in the expression
of key inflammatory mediator genes, indicating that celllacking B and T lymphocytes still develop severe arthritis
in response to this organism (Brown and Reiner, 1999). adhesion is an important regulatory stimulus, and that
adhesion triggers signal transduction pathways leadingBased on these observations, we concluded that Fes is
important for proper innate immunity, rendering c-fes2/2 to immune cell trafficking (Sporn et al., 1990; Yurochko
et al., 1992). We suggest that functional defect(s) inmice unable to respond normally to some pathogens.
c-fes2/2 macrophages such as inability to home to sites
of inflammation (e.g., skin and eye) lead to compromisedc-fes2/2 Macrophages Exhibit Adhesion Defects
innate immunity in these mice.Because of the apparent defect in innate immunity ex-
hibited by c-fes2/2 mice, we examined natural killer (NK)
cell numbers and NK cytolytic activity in mutant animals.
We determined that both NK numbers and NK func- Elevated Stat Activity in c-fes2/2 Macrophages
The results of the functional assays suggest that Fes istion were normal in c-fes2/2 animals (data not shown).
Therefore, we focused on c-fes2/2 macrophages and not playing a distinct nonredundant role in BCR- or syk-
mediated signaling, both of which are required for my-neutrophils. Inflammatory and bone marrow–derived
macrophages and neutrophils from c-fes2/2 mice were eloid cell function (Voncken et al., 1995; Kiefer et al.,
1998). To determine if Fes instead regulates Jak/Statassessed to determine whether this mutation affected
their functional properties. Surprisingly, no defects were pathways in myeloid cells, Stat3 and Stat5 activation
were assessed in response to GM-CSF, IL-3, IL-6, andobserved in c-fes2/2 macrophages and neutrophils in
many standard in vitro assays performed, including su- IL-10 treatment of c-fes2/2 macrophages and neutro-
phils. Only Stat proteins activated by phosphorylationperoxide and nitric oxide production, phagocytosis of
latex beads, response to inflammatory agents (thiogly- bind to their established DNA target sites; therefore, gel
shift analysis allows a quantification of activated Statscollate), and in vitro killing of E. coli, L. monocytogenes,
and S. aureus (data not shown). In striking contrast to within a cell. Whereas c-fes2/2 neutrophils displayed no
abnormal patterns of activation, stimulation of c-fes2/2other analyses, the ability of thioglycollate-elicited mac-
rophages to adhere to plastic petri dishes was consis- macrophages with both GM-CSF and IL-6 consistently
yielded increased Stat3 activation (Figures 5A and 5B).tently decreased. Results of six independent experi-
ments indicated that thioglycollate-elicited c-fes2/2 In response to GM-CSF, Stat3 activation was increased
z50% on average (Figure 5A, lanes 3 and 5) and inmacrophages exhibited a 45% reduction in adherence
(p 5 5.6 3 1024). This decrease in adherence suggests response to IL-6 Stat3 activation was increased 5-fold
(Figure 5B, lanes 3 and 5). No consistent differencesthat Fes is important for cell-cell and cell-extracellular
matrix adhesion events important for the inflammatory were detected with IL-3 and IL-10. Furthermore, Stat5
Immunity
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Figure 5. Increased Stat Activation in c-fes2/2 Macrophages
(A) Elevated GM-CSF-induced Stat3 DNA binding activity in c-fes2/2 macrophages. Nuclear extracts prepared from c-fes1/1 (lane 3) and c-fes2/2
(lane 5) GM-CSF stimulated bone marrow–derived macrophages were incubated with the 32P-labeled SIE oligonucleotide probe and analyzed
by EMSA. 293T cells transfected with Stat3 were used as a reference for the identification of Stat3 homodimers (ST 3/3) (lanes 9 and 10). The
position of the Stat1/Stat3 heterodimer DNA complex (ST 1/3) was confirmed by aStat1 antibody (data not shown). Prior to analysis by EMSA,
some extracts were preincubated with excess unlabeled SIE oligonucleotide (lane 6) as a specific competitor and unlabeled mutant SIE
oligonucleotide (lane 7) as a binding site specificity control. The Stat3 complexes are indicated by the arrow on the left. Dashed arrow on the
right indicates antibody supershift with aStat3 antibody. Lane 1 is free probe.
(B) Elevated GM-CSF-induced Stat5 DNA binding activity in c-fes2/2 macrophages. Nuclear extracts prepared from c-fes1/1 (lanes 3 and 4)
and c-fes2/2 (lanes 6 and 7) GM-CSF- and IL-3-stimulated bone marrow–derived macrophages were incubated with the 32P-labeled MGFE
(Stat5) oligonucleotide probe and analyzed by EMSA. Untreated extracts (lanes 2 and 5) and extracts preincubated with aStat5 (lane 10)
antibody to identify activated Stat5 are depicted. The Stat5 complex is indicated by the arrow on the left. Dashed arrow on the right indicates
antibody supershift. Lane 1 is free probe.
(C) Elevated IL-6-induced Stat3 DNA binding activity in c-fes2/2 macrophages. Nuclear extracts prepared from c-fes1/1 (lanes 2 and 3) and
c-fes2/2 (lanes 4 and 5) IL-6-stimulated bone marrow–derived macrophages were incubated with the 32P-labeled SIE oligonucleotide probe
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activation was elevated 2- to 4-fold in response to GM- c-fes1/1 macrophages when exposed to GM-CSF (n 512
for each genotype). Increased numbers of c-fes2/2 mac-CSF in c-fes2/2 macrophages (Figure 5C, lanes 3 and
6). Gel shift analysis of a ubiquitous transcription factor rophages could be due to higher division rates and/or
decreased death. Figure 6B clearly demonstrates that(Oct1) confirmed that equal amounts of nuclear proteins
were assayed in all experiments. two to three times as many c-fes2/2 macrophages enter
the cell cycle as c-fes1/1 cells upon GM-CSF treatment.The increased activation of Stat5 in response to GM-
CSF stimulation of bone marrow–derived macrophages The antiapoptotic protein BCL-xL has recently been
shown to be induced by GM-CSF in a Stat5-depen-was confirmed by Western blot analysis using an anti-
body specific for tyrosine phosphorylated Stat5 (Figure dent fashion (Kieslinger et al., 2000); therefore, we in-
vestigated the expression of BCL-2 family members in5D). Similar to the gel shift analysis, c-fes2/2 macro-
phages consistently exhibited 2- to 3-fold increases in c-fes2/2 myeloid cells. However, c-fes2/2 macrophages
exhibited normal levels of BCL-xL upon GM-CSF treat-the levels of Stat5 phosphorylation as compared to wild-
type macrophages. Importantly, c-fes2/2 macrophages ment and normal rates of apoptosis (data not shown).
We conclude that the increased numbers of c-fes2/2expressed wild-type levels of both IL-6 and GM-CSF
receptors (data not shown). Therefore, increased Stat3 macrophages produced in response to GM-CSF are not
due to increased cell survival but instead due to in-and Stat5 activation could not be attributed to elevated
levels of cytokine receptors in mutant mice. Western creased rates of mitosis. However, there is no evidence
that increased proliferation is directly caused by ele-blot analysis of total Stat1, Stat3, Stat5a, Stat5b, and
Jak2 protein levels demonstrated that Stat and Jak2 vated Stat5 phosphorylation in c-fes2/2 cells as other
components of the cell cycle machinery may be regu-protein levels were comparable in both wild-type and
mutant bone marrow–derived macrophages (data not lated by Fes.
shown). Taken together, these results demonstrate that
increased Stat activation in the absence of Fes is not the
consequence of increased expression of either growth Discussion
factor receptors or Stat proteins but instead due to in-
creased Stat phosphorylation. We have established that mutagenesis of Fes results in
Because the absence of Fes results in increased tyro- impaired viability, homeostasis defects in B cells, mac-
sine phosphorylation and activation of Stats, we hypoth- rophages, and neutrophils, compromised innate immu-
esized that endogenous Fes competes with Jak2 for nity, adhesion defects in inflammatory macrophages,
Stat phosphorylation. To test this idea, we compared and increased activation of Stat3 and Stat5 in response
the ability of Jak2 to coprecipitate Stat3 and Stat5 in to IL-6 and GM-CSF. The phenotype observed in c-fes2/2
stimulated c-fes1/1 and c-fes2/2 macrophages. Remark- mice cannot be minimized via compensation by the
ably, four times as much Stat3 coprecipitates with Jak2 closely related kinase Fer, as Fer is not highly expressed
in c-fes2/2 cells relative to c-fes1/1 macrophages (Figure in myeloid cells and Fer levels are not elevated in multi-
5E). Similar results were obtained with Stat5 (data not ple tissues harvested from c-fes2/2 mice (R. H. and
shown). These results clearly support a model whereby M. C. S., unpublished data). The reason for the impaired
Fes sequesters Stats and limits Jak2 access during cy- viability of c-fes2/2 mice is not conclusively known. How-
tokine stimulation. In the absence of Fes, more Stat ever, Fes has been shown to be expressed in vascular
proteins associate with Jak2. endothelial cells (Greer et al., 1994), and preliminary
experiments suggest that some c-fes2/2 mice are suc-
cumbing to cardiovascular defects. The abnormal num-c-fes2/2 Bone Marrow–Derived Macrophages Exhibit
ber of B lymphocytes, monocytes, and granulocytes inIncreased Proliferative Responses to GM-CSF
c-fes2/2 mice illustrates that Fes plays a role in lymphoidIt has previously been reported that Stat52/2 macro-
and myeloid homeostasis. Reduced numbers of Bphages exhibit a decreased proliferative capacity in re-
lymphoctyes in the presence of excess macrophagessponse to GM-CSF (Feldman et al., 1997). To establish
and neutrophils have been reported previously (Dorsh-if the increased Stat5 phosphorylation observed in the
kind, 1991; Lee et al., 1993; Metcalf et al., 1995; Sauva-absence of Fes correlates with increased growth of bone
geau et al., 1997), demonstrating that overproliferationmarrow macrophages in response to GM-CSF, prolifera-
of the myeloid lineage can lead to decreased B celltion assays were performed (Figure 6A). As expected
numbers.(Arai et al., 1990), we observed no proliferation in re-
c-fes2/2 inflammatory macrophages exhibit reducedsponse to IL-6 by either c-fes1/1 or c-fes2/2 macro-
adhesion on plastic petri dishes. This decrease suggestsphages in this assay (Figure 6A). No differences between
profound effects on myeloid cell inflammatory re-c-fes1/1 and c-fes2/2 macrophage proliferation in re-
sponses and normal leukocyte traffic. Cell-cell and cell-sponse to IL-3 were detected. However, c-fes2/2 macro-
phages proliferated z30% better (p 5 0.0074) than extracellular matrix adhesion events are fundamental to
and analyzed by EMSA. Prior to analysis by EMSA, some extracts were preincubated with excess unlabeled SIE oligonucleotide (lane 6) as
a specific competitor and unlabeled mutant SIE oligonucleotide (lane 7) as a binding site specificity control. The Stat3 complexes are indicated
by the arrow on the left. Dashed arrow on the right indicates antibody supershift.
(D) c-fes1/1 and c-fes2/2 bone marrow–derived macrophages were starved for 24 hr in 5% FBS prior to a 15 min stimulation with GM-CSF
(10 ng/ml). Whole cell lysates were prepared from these cells and analyzed by Western blot with anti-pStat5A/B (top) followed by anti Stat5A
(middle) and Stat5B (bottom).
(E) Lysates were prepared from c–fes1/1 and c-fes2/2 bone marrow–derived macrophages before and after GM-CSF stimulation and immunopre-
cipitated with anti-Jak2 antibodies. Following Jak2 Western blot analysis, blots were stripped and reprobed with antibodies specific to Stat3
and Stat5 (data not shown).
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Figure 7. Model for c-fes-Mediated GM-CSF Induced Stat5 Activa-
tion and IL-6 Induced Stat3 Activation
(A) In c-fes1/1 cells, both Jak2 and Fes bind and phosphorylate Stat5
in response to GM-CSF signaling. Jak2 is a more potent activator of
Stat5, resulting in robust transcription of Stat5 target genes. Fes
can also activate Stat5 but not as efficiently as Jak2. In the absence
of Fes, all of the Stat5 is accessible to the potent activator Jak2,
resulting in increased Stat5 activation.
(B) In c-fes2/2 cells, all Stat3 is accessible to Jak1, resulting in in-
creased Stat3 activation in response to IL-6. See text for details.
Figure 6. Proliferative Responses of Bone Marrow–Derived Macro-
phages to GM-CSF Such mice demonstrate that disruption of endothelial-
(A) Bone marrow–derived macrophages were incubated with the blood cell communication results in abnormal leukocyte
indicated cytokines at 10 ng/ml for 6 days, and the proliferative traffic and that adhesion is important to inflammatory
response was assayed by an MTT assay as described in the Experi- responses. Since Fes has been implicated in adhesion
mental Procedures. Results of seven independent experiments (6 signaling pathways (Kim and Wong, 1995; Jucker et al.,
standard deviation) are reported for c-fes1/1 (solid black bar) and 1997; Manfredini et al., 1997; Rosato et al., 1998), the
c-fes2/2 (white bar) macrophages. Asterisk denotes a significant
adhesion defect in c-fes2/2 mice could be due to a directdifference (P 5 0.0074) in proliferation between cells from c-fes1/1
role of Fes in adhesion-mediated signal transduction.and c-fes2/2 mice.
We propose that macrophage adhesion defects contrib-(B) GM-CSF-stimulated macrophages were analyzed for cell cycle
ute to the abnormal innate immunity exhibited by c-fes2/2progression at 4 days post stimulation. G1, S, and G2/M peaks are
indicated. mice.
Fes has been linked to the Jak-Stat pathway (Brizzi
et al., 1996; Nelson et al., 1998; Park et al., 1998), andthe inflammatory process. During inflammation, extrava-
in its absence macrophages exhibit increased activationsating myeloid cells interact with vascular and connec-
of both Stat3 and Stat5. It is possible that Fes actstive tissue cells and with extracellular matrix proteins
indirectly to inhibit Stat activation. For instance, thereusing integrins and other adhesion receptors (Osborn,
may be a Fes-dependent negative feedback mechanism1990; Butcher, 1991). Other mutations have been gener-
acting downstream of Stat. However, both Jak and Fesated that result in adhesion defects leading to compro-
appear to activate Stat3 and Stat5 (Brizzi et al., 1996;mised innate immunity, such as the genes encoding P-
Rajotte et al., 1996; Nelson et al., 1998; Park et al., 1998).and E-selectin (Frenette et al., 1996). P- and E-selectin
Therefore, we propose the following model (Figure 7A):are adhesion molecules expressed on endothelial cells
Jak2 and Fes bind and phosphorylate Stat5 in responseimportant for recruitment of macrophages and neutro-
to GM-CSF signaling. If Jak2 is a more potent activatorphils in response to inflammation. P-selectin2/2/E-selec-
of Stat5, Jak2 interactions with Stat5 result in robusttin2/2 mice exhibit increased neutrophil and macro-
phage numbers and develop ulcerative skin lesions. transcription of Stat5 target genes. We suggest that Fes
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to delete the entire c-fes promoter and translational start codon. Aactivates Stat5 less efficiently than Jak2. Therefore, Fes
c-fes targeting vector was generated by insertion of a 8.5 kb frag-acts as a negative regulator of Jak2 activation of Stat5
ment containing the 39 end of the c-fes locus into the NotI/XhoI siteby sequestering Stat5 and limiting Jak2 access. Impor-
of pPNT (Tybulewicz et al., 1991), followed by ligation of a 1.6 kbtantly, increased levels of Stat3 and Stat5 bind Jak2
fragment containing the 59 end of the c-fes locus into the BamHI/
in c-fes2/2 macrophages stimulated with GM-CSF (see XbaI site (see Figure 1). The resulting construct was linearized by
Figure 5E), indicating that Fes interferes with Jak2/Stat NotI digestion and electroporated into RW4 ES cells (Bradley et al.,
interactions. A similar model can account for increased 1984). Homologous recombinants selected by G418 (250 mg/ml) and
Stat3 activation in response to IL-6 (Figure 7B). This gancyclovir (1 mM) were screened by Southern blotting for presence
of a recombinant 7 kb BglII fragment, in addition to the endogenousrepresents a novel way to regulate Stat function during
9.4 kb fragment, using a radiolabeled 360 bp SalI/SalI probe fromcytokine-mediated signal transduction.
the c-fes gene. To generate homozygous mutant cell lines, c-fes1/2A recent paper from Senis et al. (1999) lends additional
ES were cultured in the presence of increasing concentrations ofsupport to our model. This group generated an allele of
G418 (1.0–2.0 mg/ml) (Mortensen et al., 1992), and surviving coloniesc-fes producing normal levels of autophosphorylation-
were assayed for loss of the wild-type c-fes allele.
deficient, kinase-dead Fes protein. Their mutant animals
exhibit slightly elevated total leukocyte counts, spleno-
In Vitro Differentiation and Immunocytochemistry of ES Cells
megaly, and slightly increased numbers of CFU-GM in c-fes1/1, c-fes1/2, and c-fes2/2 ES cells were in vitro differentiated
response to IL-3 and GM-CSF. While such mice exhibit under the conditions described previously (Olson et al., 1995). After
only mild perturbations in myeloid cell numbers, mutant 11 days in methylcellulose medium, adherent cells were harvested,
macrophages display striking reductions in the levels fixed with glutaraldehyde-acetone (Sigma), and stained using the
Vectastain ABC-alkaline phosphatase kit (Vector Laboratories, Bur-of Stat3 and Stat5 activation in response to GM-CSF.
lingame, California). Primary antibodies used in the staining proce-This is consistent with a recent observation that kinase-
dure were rat antibodies that recognized the mouse macrophagedead Fes leads to decreased Stat3 activation in TF1
F4/80 and CD11b antigens (Caltag, San Francisco, California).myeloid cells in response to GM-CSF (Park et al., 1998).
As kinase-dead Fes can still bind to Stat3 in TF-1 cells
Flow Cytometry Analysis(Park et al., 1998), it is likely that the autophosphorylation
Single cell suspensions were prepared from the indicated tissues,
mutant binds to both Stat3 and Stat5 but cannot activate stained, and analyzed on a dual laser cell sorter (FACSCAN, Becton
them. In c-fes null cells, Stats are not titrated away Dickinson). Propidium iodide uptake and scatter-gating for size were
from Jak2, resulting in maximal Stat activation. Taken used to exclude dead cells from the analysis. Anti-CD4, anti-CD8,
together, our null c-fes allele and the c-fes kinase-defi- anti-IgM, anti-B220, anti-GR-1, anti-CD11b, and anti-CD18 mono-
clonal antibodies were used according to the instructions of thecient allele establish that Fes is an important component
supplier (PharMingen, San Diego, CA). For cell cycle analysis, GM-of Stat regulation in response to GM-CSF and IL-6 sig-
CSF-stimulated cell samples were harvested, fixed in 70% ETOH,naling.
and treated with RNase A and propidium iodide as previously de-The proposed ability of both Jaks and Fes to bind
scribed (Crissman and Steinkamp, 1973).and activate Stats provide an additional level of control
in the Jak/Stat signaling pathway. Specifically, altered
Hematopoietic Progenitor Cell Assays
levels of Jaks or Fes would lead to modulated levels of Bone marrow cells (2 3 104) and splenic cells (1 3 105) were plated
activated Stat factors. In the context of GM-CSF and in 1 ml of complete methylcellulose media (MethoCult HCC3434,
IL-6 signaling, this could result in increased proliferation, Stem Cell Technologies) supplemented with pokeweed mitogen-
inappropriate differentiation, and/or activation defects. stimulated murine spleen cell-conditioned medium (MethoCult
M3430) and penicillin-streptomycin. Colonies were counted on daysAs shown in Figure 6, GM-CSF stimulation results in
7–8. Colony identity was confirmed by cytocentrifugation and May-increased proliferation in c-fes2/2 macrophages. We
Grunwald-Giemsa staining.suggest that increased cytokine responsiveness results
in elevated numbers of myeloid cells in c-fes2/2 mice.
Cell Culture and Adherence AssaysAlthough other pathways may be regulated by Fes, Stat5
Bone marrow cells were obtained from the femur, tibia, and hu-has been shown to activate components of the cell cycle
merus. Bone marrow–derived macrophages were obtained by seed-
machinery (Matsumura et al., 1999) and correlates with ing bone marrow cells (6 3 106) into 10 ml of macrophage medium
the GM-CSF phenotype. Future experiments will deter- (DMEM [Gibco-BRL], supplemented with 30% L929 cell conditioned
mine if abnormal Stat5 activation directly leads to in- supernatant, 20% FBS, 2 mM glutamine, and 0.5 mM 2-mercaptoeth-
creased proliferation in mutant macrophages. In a physi- anol) in plastic petri dishes. After 8–12 days of culture, the cells
were used as bone marrow macrophages for functional assays,ologic setting where cells are exposed to numerous
nuclear extracts, and lysates. Bone marrow neutrophils were puri-stimuli simultaneously, signaling responses to cytokines
fied by Percoll step gradient as previously described (Kiefer et al.,are regulated by an interplay among positive and nega-
1998). Neutrophil preparations were used within 24 hr of isolation.tive factors. Our results indicate that Fes is a key regula-
Thioglycollate-elicited macrophages and neutrophils were preparedtor in responses to GM-CSF and IL-6 stimulation by
by intraperitoneal injection of 2 ml 2% thioglycollate broth (Gibco-
modulating the effects of Stat3 and Stat5. Because of BRL), followed by flushing the peritoneal cavity with PBS 4 days
its role in GM-CSF and IL-6 signaling, c-fes is important later for purification of macrophages and 4 hr later for purification
for the complex processes of homeostasis, innate im- of neutrophils. Thioglycollate-elicited macrophages were cultured
munity, and myeloid cell differentiation. in macrophage media for 5 days for adhesion assays. At the end
of this period, the dishes were vigorously washed three times with
PBS, and remaining adherent cells were removed and enumeratedExperimental Procedures
using both a hemacytometer and a Coulter counter.
Targeting Construct and Generation of c-fes2/2 ES Cells and Mice
A genomic library from strain 129 mice (Strategene) was screened Nuclear Extract Preparation and Electrophoretic
Mobility Shift Assaywith a partial cDNA for the mouse c-fes generated by RT-PCR using
murine c-fes-specific primers (Wilks and Kurban, 1988). An 18 kb Purified bone marrow macrophages and neutrophils were cultured
overnight in 10% FBS and then 0% serum for 2 hr prior to stimulation.genomic clone encoding the entire c-fes genomic locus was isolated
and characterized. The neomycinR targeting construct was designed Cells were stimulated for 15 min with 1 ng/ml GM-CSF, IL-3, IL-6,
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or IL-10. Stimulated cells were subjected to nuclear extract prepara- lyme arthritis in the absence of specific immunity. Infect. Immun.
67, 1967–1973.tion by the method of Andrews and Faller (1991). For electrophoretic
mobility shift assays (EMSAs), 5 mg of nuclear extract was incubated Butcher, E.C. (1991). Leukocyte-endothelial cell recognition: three
with 10,000 CPM of each radiolabeled probe as described previously (or more) steps to specificity and diversity. Cell 67, 1033–1036.
(Ip et al., 1994). Binding buffers contained 10 mM Tris-HCl (pH 7.5),
Crissman, H.A., and Steinkamp, J.A. (1973). Rapid simultaneous
1 mM EDTA, 4% ficoll, 75 mM KCl, and 1 mM DTT. Where indicated,
measurement of DNA, protein, and cell volume in single cells from
100 ng of cold competitor oligonucleotide or 2 mg of indicated anti-
large mammalian cell populations. J. Cell Biol. 59, 766–771.
body was added to reactions 30 min prior to the addition of the
Darnell, J.E., Jr. (1997). Stats and gene regulation. Science 277,labeled probe. Quantification was achieved using a Molecular Dy-
1630–1635.namics PhosphorImager. The polyclonal antisera specific for Stat5
Darnell, J.E., Jr., Kerr, I.M., and Stark, G.R. (1994). Jak-Stat pathwayswas purchased from Santa Cruz Biotechnology, and the Stat3,
and transcriptional activation in response to IFNs and other extracel-Stat5a, and Stat5b antisera were obtained from Zymed.
lular signaling proteins. Science 264, 1415–1421.The following oligonucleotides were utilized: Stat3 WT (SIE),
59-GATCAGCTTCATTTCCCGTAAATCCCTA-39 (Wagner et al., Dorshkind, K. (1991). In vivo administration of recombinant granulo-
1990); Stat3 MT (SIE), 59-GATCAGCTTCAGATCCCGTCATTCCTA-39 cyte-macrophage colony-stimulating factor results in a reversible
(Wagner et al., 1990); Stat5 WT (MGFE), 59-GATCAGATTTCTAG inhibition of primary B lymphopoiesis. J. Immunol. 146, 4204–4208.
GAATTCAATCC-39 (Pallard et al., 1995); Stat5 MT (MGFE), 59-GAT Feldman, R.A., Gabrilove, J.L., Tam, J.P., Moore, M.A.S., and Hana-
CAGATTTAGTTTAATTCAATCC-39 (Pallard et al., 1995); OCT WT, fusa, H. (1985). Specific expression of the human cellular fps/fes-
59-GATCCTTAATAATTTGCATACCCTCA-39 (Strubin et al., 1995); encoded protein NCP92 in normal and leukemic myeloid cells. Proc.
and OCT MUT, 59-GATCCTTAATAACTTGCATACCCTCA-39 (Strubin Natl. Acad. Sci. 82, 2379–2383.
et al., 1995).
Feldman, R.A., Lowy, D.R., and Vass, W.C. (1990). Selective potenti-
ation of c-fps/fes transforming activity by a phosphatase inhibitor.
Western Blot Analysis
Oncogene Res. 5, 187–197.
Fes immunoprecipitation and Western blot analysis were carried
Feldman, G.M., Rosenthal, L.A., Liu, X., Hayes, M.P., Wynshaw-out as previously described (Feldman et al., 1990). An anti-Fes poly-
Boris, A., Leonard, W.J., Hennighausen, L., and Finbloom, D.S.clonal antibody was used for immunoprecipitation, and two different
(1997). Stat5A-deficient mice demonstrate a defect in granulocyte-anti-Fes monoclonal antibodies directed against the Fes tyrosine
macrophage colony-stimulating factor-induced proliferation andkinase domain were utilized for Westerns. Polyclonal antisera spe-
gene expression. Blood 90, 1768–1776.cific for Stat1, Stat3, Stat5a, Stat5b, Stat5-P, and Jak2 were pur-
Ferrari, S., Manfredini, R., Grande, A., and Torelli, U. (1992). Anti-chased from Zymed. Immunoprecipitations were performed as de-
sense strategies to characterize the role of genes and oncogenesscribed (Garrett-Sinha et al., 1999).
involved in myeloid differentiation. Ann. NY Acad. Sci. 660, 11–26.
Proliferation Assay Frenette, P.S., Mayadas, T.N., Rayburn, H., Hynes, R.O., and
Confluent plates of bone marrow–derived macrophages starved for Wagner, D.D. (1996). Susceptibility to infection and altered hemato-
M-CSF for 24 hr were washed with PBS and harvested. Cells were poiesis in mice deficient in both P- and E-selectins. Cell 84, 563–574.
plated in 96-well tissue culture dishes at 5 3 104 cells per well in Garrett-Sinha, L.A., Su, G.H., Rao, S., Kabak, S., Hao, Z., Clark, M.R.,
200 ml of DMEM containing 10% FBS and 10 ng/ml of either IL-3, and Simon, M.C. (1999). PU.1 and Spi-B are required for normal B
IL-6, or GM-CSF (R&D Systems). After 6 days in culture, 25 ml of a cell receptor-mediated signal transduction. Immunity 10, 399–408.
5 mg/ml solution of MTT (dimethyl thiazole diphenyl tetrazolium
Glazer, R.I., Chapekar, M.S., Hartman, K.D., and Knode, M.C. (1986).bromide; Sigma) in PBS was added to all wells and incubated for
Appearance of membrane-bound tyrosine kinase during differentia-2 hr at 378C. 125 ul of 10%SDS/0.01N HCl was added to each well,
tion of HL-60 leukemia cells by immune interferon and tumor necro-and absorbance was read at 570 nm.
sis factor. Biochem. Biophys. Res. Comm. 140, 905–915.
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